Loading...
Loading...
Receptos, Inc. RCPT was a big mover last session, as the company saw its shares surge a whopping 37% on the day. This tremendous rally can be attributable to solid volume too with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $24.99 to $30.43 in the past one-month time frame.
The company has seen 2 negative revisions in the past 1 month, while its Zacks Consensus Estimate of a loss widened over the same period, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Receptos currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Other attractive players in the healthcare industry include Illumina Inc. ILMN and Gilead Sciences Inc. GILD, carrying a Zacks Rank #1 (Strong Buy) and Ariad Pharmaceuticals Inc. ARIA with a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free reportRECEPTOS INC RCPT: Free Stock Analysis Report
ILLUMINA INC ILMN: Free Stock Analysis Report
GILEAD SCIENCES GILD: Free Stock Analysis Report
ARIAD PHARMA ARIA: Free Stock Analysis Report
To read this article on Zacks.com click here.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in